New York Life Investment Management LLC Charles River Laboratories International, Inc. Transaction History
New York Life Investment Management LLC
- $9.34 Billion
- Q2 2024
A detailed history of New York Life Investment Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 13,560 shares of CRL stock, worth $2.53 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,560
Previous 12,199
11.16%
Holding current value
$2.53 Million
Previous $3.31 Million
15.25%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding CRL
# of Institutions
721Shares Held
52MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$949 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$390 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$356 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$328 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...